Rossari Biotech Share Price

503.9515.31 (3.14%)

Closed
As On: 12 Jun, 2026, 03:53 PM IST
As On: 12 Jun, 2026, 03:40 PM IST

Sector: Chemicals
Industry: Chemicals - Specia...

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	498.00
High	512.00
Low	490.60
Prev Close	488.65
Volume	1,15,938
VWAP(₹)	501.59

Share Price	Value
Today/Current/Last	503.95502.35
Previous Day	488.65488.90

Rossari Biotech Share Recommendations

Mean recosCurrent

BUY

4 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	2	2	2	1
Buy	1	1	1	3
Hold	1	1	1	1
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	4	4	4	5

Recent Recos

Target₹885
OrganizationICICI Securities
ADD

Target₹1095
OrganizationYes Securities
BUY

Target₹910
OrganizationICICI Securities
HOLD

View all Stock Recommendations

News & Analysis

View all Rossari Biotech Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	703.93	582.19	587.71	544.92	581.35
Total Income Growth (%)	20.91	-0.94	7.85	-6.27	13.26
Total Expenses	631.14	532.42	532.42	493.61	528.29
Total Expenses Growth (%)	18.54	0.00	7.86	-6.56	13.30
EBIT	72.79	49.77	55.30	51.31	53.06
EBIT Growth (%)	46.25	-10.00	7.77	-3.31	12.92
Profit after Tax (PAT)	45.97	32.77	36.88	33.60	34.44
PAT Growth (%)	40.25	-11.12	9.76	-2.46	8.65
EBIT Margin (%)	10.34	8.55	9.41	9.42	9.13
Net Profit Margin (%)	6.53	5.63	6.27	6.17	5.92
Basic EPS (₹)	8.30	5.92	6.66	6.07	6.22

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	538.87	451.80	420.91	367.50	429.05
Total Income Growth (%)	19.27	7.34	14.53	-14.35	16.18
Total Expenses	461.51	407.75	376.44	328.96	382.12
Total Expenses Growth (%)	13.19	8.32	14.43	-13.91	17.31
EBIT	77.36	44.05	44.47	38.54	46.93
EBIT Growth (%)	75.60	-0.93	15.38	-17.89	7.79
Profit after Tax (PAT)	54.73	30.63	31.25	26.23	32.36
PAT Growth (%)	78.70	-1.99	19.12	-18.94	5.66
EBIT Margin (%)	14.36	9.75	10.56	10.49	10.94
Net Profit Margin (%)	10.16	6.78	7.42	7.14	7.54
Basic EPS (₹)	9.88	5.53	5.64	4.74	5.85

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,418.74	2,084.30	1,838.00	1,661.37	1,494.97
Total Revenue Growth (%)	16.05	13.40	10.63	11.13	108.06
Total Expenses	2,218.13	1,900.10	1,660.56	1,518.10	1,360.24
Total Expenses Growth (%)	16.74	14.42	9.38	11.61	122.22
Profit after Tax (PAT)	149.21	136.38	130.69	107.26	97.67
PAT Growth (%)	9.41	4.35	21.85	9.81	21.76
Operating Profit Margin (%)	9.56	9.71	10.75	9.99	9.93
Net Profit Margin (%)	6.22	6.55	7.13	6.47	6.58
Basic EPS (₹)	26.95	24.66	23.67	19.46	17.81

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,779.08	1,437.37	1,209.68	978.77	1,085.54
Total Revenue Growth (%)	23.77	18.82	23.59	-9.84	54.94
Total Expenses	1,588.01	1,282.67	1,075.55	883.13	978.86
Total Expenses Growth (%)	23.81	19.26	21.79	-9.78	64.62
Profit after Tax (PAT)	142.84	114.74	99.65	71.39	79.47
PAT Growth (%)	24.49	15.15	39.58	-10.17	0.47
Operating Profit Margin (%)	11.66	11.47	11.95	10.28	10.18
Net Profit Margin (%)	8.15	8.01	8.28	7.32	7.40
Basic EPS (₹)	25.79	20.75	18.05	12.95	14.49

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 20.91%, which is highest in the last 3 years. (Source: Consolidated Financials)
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 16.05% outperformed its 3 year CAGR of 13.2%. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	2,288.79	1,896.18	1,572.15	1,367.57	1,256.72
Total Assets Growth (%)	20.71	20.61	14.96	8.82	123.88
Total Liabilities	955.44	710.74	524.42	452.40	451.56
Total Liabilities Growth (%)	34.43	35.53	15.92	0.19	195.96
Total Equity	1,333.35	1,185.45	1,047.73	915.17	805.16
Total Equity Growth (%)	12.48	13.14	14.49	13.66	96.97
Current Ratio (x)	1.58	1.94	1.99	2.08	2.07
Total Debt to Equity (x)	0.31	0.16	0.10	0.08	0.01
Contingent Liabilities	0.00	1.98	5.44	19.96	2.61

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,763.64	1,450.92	1,281.17	1,125.67	925.93
Total Assets Growth (%)	21.55	13.25	13.81	21.57	70.10
Total Liabilities	545.14	373.75	320.83	266.97	141.41
Total Liabilities Growth (%)	45.86	16.49	20.17	88.79	1.06
Total Equity	1,218.49	1,077.17	960.34	858.70	784.52
Total Equity Growth (%)	13.12	12.17	11.84	9.46	93.98
Current Ratio (x)	1.73	1.97	2.01	2.05	2.63
Total Debt to Equity (x)	0.10	0.03	0.06	0.08	0.00
Contingent Liabilities	0.00	236.48	94.11	125.56	178.26

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	65.07	137.44	43.26	152.39	29.36
Net Cash used in Investing Activities	-219.48	-183.70	-103.21	-180.89	-298.88
Net Cash flow from Financing Activities	186.32	64.90	16.19	60.86	291.79
Net Cash Flow	31.11	19.03	-44.03	32.36	22.27
Closing Cash & Cash Equivalent	75.31	44.20	25.17	69.83	37.48
Closing Cash & Cash Equivalent Growth (%)	70.37	75.61	-63.96	86.33	146.43
Total Debt/ CFO (x)	6.27	1.37	2.45	0.49	0.29

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	58.73	92.20	73.92	113.66	33.12
Net Cash used in Investing Activities	-101.40	-69.92	-69.55	-160.59	-318.12
Net Cash flow from Financing Activities	79.13	-32.27	-22.09	61.21	296.91
Net Cash Flow	35.74	-9.64	-17.95	14.28	11.91
Closing Cash & Cash Equivalent	48.65	12.91	22.55	41.02	26.74
Closing Cash & Cash Equivalent Growth (%)	276.94	-42.76	-45.04	53.40	80.31
Total Debt/ CFO (x)	2.15	0.33	0.74	0.57	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 65.07 cr is 0.44 times compared to the reported net profit of Rs 149.21 cr. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 219.48 cr for investing activities which is an YoY increase of 19.48%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	11.19	11.50	12.47	11.71	12.13
Return on Capital Employed (%)	15.28	14.85	17.15	16.22	15.31
Return on Assets (%)	6.51	7.19	8.31	7.84	7.77
Interest Coverage Ratio (x)	10.80	15.11	13.28	10.24	15.44
Asset Turnover Ratio (x)	1.15	1.20	1.25	1.26	1.63
Price to Earnings (x)	14.04	24.57	28.57	30.67	51.55
Price to Book (x)	1.57	2.82	3.56	3.59	6.25
EV/EBITDA (x)	7.82	12.91	14.78	14.15	25.51
EBITDA Margin (%)	12.86	12.93	14.05	13.79	13.17

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	11.72	10.65	10.37	8.31	10.13
Return on Capital Employed (%)	16.45	14.98	14.41	11.19	13.90
Return on Assets (%)	8.09	7.90	7.77	6.34	8.58
Interest Coverage Ratio (x)	17.63	20.03	17.32	27.34	53.24
Asset Turnover Ratio (x)	1.09	1.05	1.00	0.95	1.46
Price to Earnings (x)	14.68	29.15	37.45	46.08	63.29
Price to Book (x)	1.72	3.10	3.88	3.82	6.41
EV/EBITDA (x)	9.22	17.49	22.35	25.88	36.86
EBITDA Margin (%)	13.43	13.40	13.96	12.94	12.62

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Rossari Biotech	18.71	2.09	11.19	15.28	6.51	13.20	9.56	6.14	26.95	1.58	0.31	6.27
Gujarat Fluorochem	69.47	5.07	7.34	10.36	4.86	-4.85	19.33	11.50	52.26	1.72	0.28	2.29
Jubilant Ingrevia	35.73	3.18	8.88	11.10	5.06	-2.66	9.84	6.33	17.59	1.29	0.25	1.51
Clean Science & Tech	35.62	5.16	14.50	19.16	12.88	0.80	32.41	24.00	21.61	5.01	0.00	0.00
Rain Ind.	21.95	0.86	0.57	8.13	0.20	-6.75	7.98	0.78	1.26	1.87	1.21	10.08
Add More

Annual Ratios (%)

Choose from Peers

Galaxy Surfactants
NOCIL Ltd
Vidhi Specialty Food
Vikas Ecotech
Chembond Chem

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Rossari Biotech Stock Performance	3.14	-3.31	-1.76	-1.23	-23.20	-30.22	-56.97
Gujarat Fluorochem Stock Performance	-0.69	-0.98	11.87	6.70	-8.57	10.37	339.87
Jubilant Ingrevia Stock Performance	0.98	-15.16	-5.37	3.49	-7.92	60.46	42.67
Clean Science & Tech Stock Performance	3.85	-5.92	2.36	8.23	-39.62	-48.57	0.00
Rain Ind. Stock Performance	1.12	22.79	50.13	35.28	35.16	34.11	13.18
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	3,77,45,500	68.15 %	0.00
Pledge	0	0.00 %	0.00
FII	12,08,056	2.17 %	-0.14
DII	1,00,80,900	18.21 %	-0.03
MF	74,07,876	13.38 %	-0.08
Others	63,48,910	11.46 %	0.19

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	68.15	68.16	68.17	68.17
Pledge	0.00	0.00	0.00	0.00
FII	2.17	2.32	2.69	3.48
DII	18.21	18.25	18.18	17.84
Mutual Funds	13.38	13.47	13.27	13.42
Others	11.46	11.27	10.96	10.50

Mutual Funds Ownership

MF Ownership as on 30 April 2026

UTI Flexi Cap Direct-G
Equity: Flexi Cap
1
- 81.42
  Amount Invested (in Cr.)
- 0.36729989%
  % of AUM
- 0.00
  % Change (MoM basis)
Canara Robeco Small Cap Direct-G
Equity: Small Cap
3
- 50.97
  Amount Invested (in Cr.)
- 0.38%
  % of AUM
- -0.28
  % Change (MoM basis)
Motilal Oswal Small Cap Direct-G
Equity: Small Cap
- 39.15
  Amount Invested (in Cr.)
- 0.63085777%
  % of AUM
- -4.46
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Final
25%
Apr 27, 2026
Board Meeting
Audited Results & Final Dividend
Apr 20, 2026
Board Meeting
Quarterly Results
Jan 12, 2026

Board Meetings

Announced on	Meeting on
Apr 20, 2026	Apr 27, 2026
Audited Results & Final Dividend
Jan 12, 2026	Jan 17, 2026
Quarterly Results
Oct 08, 2025	Oct 15, 2025
Quarterly Results
Jul 11, 2025	Jul 19, 2025
Quarterly Results
Apr 21, 2025	Apr 25, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
Apr 25, 2025 Jun 20, 2025 25%
Apr 29, 2024 Aug 16, 2024 25%
May 02, 2023 May 24, 2023 25%
May 20, 2022 Jul 07, 2022 25%
Apr 27, 2026 - 25%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

Announced on	Ex-Date	Dividend%
Apr 25, 2025	Jun 20, 2025	25%
Apr 29, 2024	Aug 16, 2024	25%
May 02, 2023	May 24, 2023	25%
May 20, 2022	Jul 07, 2022	25%
Apr 27, 2026	-	25%

AGM/EGM Meetings

Announced on	Meeting on
May 29, 2025	Jun 30, 2025
-
Oct 21, 2024	Nov 11, 2024
Book closure from Nov 5, 2024 to Nov 11, 2024
Jul 23, 2024	-
Book closure from Aug 17, 2024 to Aug 23, 2024
Jul 23, 2024	-
Book closure from Aug 17, 2024 to Aug 23, 2024
Jul 23, 2024	-
Book closure from Aug 17, 2024 to Aug 23, 2024

About Rossari Biotech

Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 2,791.04 Crore) operating in Chemicals sector.

Rossari Biotech Ltd. key Products/Revenue Segments include Organic/Inorganic Heavy Chemicals, Commission and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 703.93 Crore, up 20.91 % from last quarter Total Income of Rs 582.19 Crore and up 21.08 % from last year same quarter Total Income of Rs 581.35 Crore. Company has reported net profit after tax of Rs 45.45 Crore in latest quarter.

The company’s top management includes Mr.Edward Menezes, Mr.Sunil Chari, Ms.Aparna Sharma, Mr.Aseem Dhru, Ms.Esha Achan, Mr.Gurudas Aras, Mr.Ketan Sablok, Ms.Parul Gupta. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 5.54 Crore shares outstanding.

Rossari Biotech Share Price Today is Rs. 503.95. On previous day, the Rossari Biotech Share Price (NSE) closed at Rs. 488.65, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 68.15% of the stake in Rossari Biotech shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Rossari Biotech stocks was 2.18% as compared to 2.32% in Dec 2025 with decrease of 0.14%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 18.21% as compared to 18.25% in Dec 2025 with decrease of 0.04%. Out of the total DII holdings in Rossari Biotech shares 13.38% was held by mutual funds. The rest including public held is 11.46%. Rossari Biotech stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Rossari Biotech Dividend: Ever since 2009, Rossari Biotech dividends has been paid out around 6 times. As on 12 Jun, 2026, 03:53 PM IST, The overall dividend yield for Rossari Biotech stands at 0.1%. The last dividend paid was on June 20, 2025 (Rs. 0.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 26.94.

Rossari Biotech Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 703.93 Cr. of sales and 20.91% of quarterly net profit, there have been multiple ups and downs in the Rossari Biotech stock prices in the past few weeks. For example, Rossari Biotech stock price on 5th of June 2026 was around Rs. 527.0. Rossari Biotech share price now stands at an average of Rs. 503.95. Judging by last week's performance, stock is in down trend.

Rossari Biotech has a median target price of Rs. 601.75 in 12 months by 4 analysts. They have provided a high estimate of Rs. 637.0 and low estimate of Rs. 570.0 for Rossari Biotech share.

Historical Prices and Performance:
Rossari Biotech, incorporated in 2009 is a Small Cap company (with a market cap of Rs. 2791.04) operating in Chemicals sector.
The Return of Equity (ROE) in last five financial years given by Rossari Biotech stock was 11.19%, 11.5%, 12.47%, 11.71% and 12.13% respectively.
The Rossari Biotech share gave a 3 year return of -40.22% as compared to Nifty 50 which gave a return of 26.99%.
Rossari Biotech announced 25.0% final dividend on June 20, 2025.

Key Metrics:
PE Ratio of Rossari Biotech is 18.71
Prices/Sales Ratio of Rossari Biotech is 0.87
Price/Book Ratio of Rossari Biotech is 2.09

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Rossari Biotech, major competitors and peers include Gujarat Fluorochem, Jubilant Ingrevia, Clean Science & Tech and Rain Ind.. As of Dec 2025, the dividend yield of Rossari Biotech stands at 0.1% while Gujarat Fluorochem, Jubilant Ingrevia, Clean Science & Tech and Rain Ind. stand at 0.0%, 0.0%, 0.78% and 0.51% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 18.71 and 2.09 respectively.

Leadership of Rossari Biotech :
Parul Gupta is Co. Secretary & Compl. Officer
Ketan Sablok is Group Chief Financial Officer
Edward Menezes is Executive Chairman
Sunil Chari is Managing Director
Aseem Dhru is Independent Director
Aparna Sharma is Independent Director
Esha Achan is Independent Director
Gurudas Aras is Independent Director

Industry

Chemicals - Speciality - Others

Key Indices Listed On

BSE SmallCap, BSE Commodities, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

Rossari House, Golden Oak,LBS Marg, Surya Nagar,Opp. Mahindra Showroom,Mumbai, Maharashtra - 400079

Contact

investors@rossari.com

http://www.rossari.com

PE Ratio(x)	18.71
EPS - TTM(₹)	26.94
MCap(₹ Cr.)	2,791.04
MCap Rank	40
PB Ratio(x)	2.12
Div Yield(%)	0.10
Face Value(₹)	2.00
52W High(₹)	766.00
52W Low(₹)	375.00
MCap/Sales	0.87
Beta(1 Month)	-
BV/Share(₹)	240.75

PE Ratio(x)	18.65
EPS - TTM(₹)	26.94
MCap(₹ Cr.)	2,782.18
MCap Rank	41
PB Ratio(x)	2.02
Div Yield(%)	0.10
Face Value(₹)	2.00
52W High(₹)	767.55
52W Low(₹)	372.90
MCap/Sales	0.87
Beta(1 Month)	-
BV/Share(₹)	240.75

1 Day	3.14%
1 Month	-0.65%
3 Months	11.19%
1 Year	-25.86%
3 Years	-40.22%
5 Years	-59.36%

1 Day	2.75%
1 Month	-0.98%
3 Months	10.71%
1 Year	-26.05%
3 Years	-40.31%
5 Years	-59.46%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Rossari Biotech Share Price

Key Metrics